Table 1.

Timeline for IMRA and Madeglucyl development

1958	Albert Rakoto-Ratsimamanga establishes IMRA
1965	Albert Rakoto-Ratsimamanga and Suzanne Ratsimamanga begin to work with local healers
1970	IMRA launches its Syzygium cumini (Madeglucyl) project
1984	Initial license for Madeglucyl is registered in Paris
1985	Professors study and experiment with Syzygium cumini seeds at IMRA and the University of Paris.
1993	IMRA is awarded official status as a foundation by government decree
1996	Second license is issued, granting Madeglucyl international recognition
1997	New Drug Application for Madeglucyl is filed and approved in Madagascar
1998	Total harvest of Syzygium cumini seeds reaches 20 tonnes
2007	Production capacity for Madeglucyl reaches 20kg/day (5g/package)